Strisun Drugs LLP
About Strisun Drugs LLP
Data last updated:
Strisun Drugs LLP is a limited liability partnership (LLP) based in Mumbai, Maharashtra, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 19 June 2020 and has been in existence for over 6 years.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAS-6614. Its GSTIN is 27AEEFS6310K1ZW (Maharashtra).
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Abu Saria and Dhruv Kirit Gala.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at G 1701 Octacrest Lokhandwala Township Akurli Road Kandivali (East), Mumbai, Maharashtra, India – 400101.
As per MCA filings, the LLP has open charges of ₹8 Cr and satisfied charges of ₹2 Cr on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressG 1701 Octacrest Lokhandwala Township Akurli Road Kandivali (East), Mumbai, Maharashtra, India – 400101
- IndustryHealthcare, Medical & Laboratory Equipment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Strisun Drugs LLP FY 2025 filings available
Financial Statement Summary of Strisun Drugs LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Strisun Drugs LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Strisun Drugs are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Strisun Drugs LLP
Strisun Drugs has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abu Saria | Designated Partner | 19 Jun 2020 | 6 Years 3 Months | Current |
| Dhruv Kirit Gala Also directs: Saria & Gala Ventures LLP, Strisun Foods Private Limited | Designated Partner | 19 Jun 2020 | 6 Years 3 Months | Current |
Charges & Borrowings of Strisun Drugs LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Mar 2025 | Icici Bank Limited | ₹8 Cr | Open |
| 29 Dec 2022 | Idfc First Bank Limited | ₹2 Cr | Satisfied |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Strisun Drugs LLP
Employment history and EPFO contributions of people linked to Strisun Drugs.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Strisun Drugs LLP
Strisun Drugs LLP has 2 designated partner changes on record since 2020: 2 appointments. The latest: Abu Saria was appointed as Designated Partner on 19 Jun 2020.
Credit Ratings, Litigation & Regulatory Alerts for Strisun Drugs LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Strisun Drugs LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Strisun Drugs LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Strisun Drugs LLP
Strisun Drugs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AEEFS6310K1ZW | Maharashtra | Active | 01 Sep 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Strisun Drugs LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Strisun Drugs LLP
Strisun Drugs is an active limited liability partnership based in Mumbai, Maharashtra, India. The LLP works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 19 June 2020 (6+ years old) and is registered under LLPIN AAS-6614.
Strisun Drugs has 2 current designated partners:
- Abu Saria - Designated Partner
- Dhruv Kirit Gala - Designated Partner
The GSTIN of Strisun Drugs is 27AEEFS6310K1ZW, registered in Maharashtra.
The LLPIN (Limited Liability Partnership Identification Number) of Strisun Drugs is AAS-6614. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Strisun Drugs was incorporated on 19 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Abu Saria was appointed as Designated Partner on 19 Jun 2020. Dhruv Kirit Gala was appointed as Designated Partner on 19 Jun 2020.
The registered office of Strisun Drugs is at G 1701 Octacrest Lokhandwala Township Akurli Road Kandivali East, Mumbai, Maharashtra, India – 400101.
The total obligation of contribution is ₹1 Lakh.
Strisun Drugs operates in the healthcare industry, in the medical and laboratory equipment segment.
Strisun Drugs has open charges of ₹8 Cr and satisfied charges of ₹2 Cr as per latest MCA filings.